Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial
Pre-publication versions of this article are available by contacting email@example.com.
|6 Jan 2013||Submitted||Original manuscript|
|11 Feb 2013||Author responded||Author comments - Chiara Zecca|
|Resubmission - Version 2|
|11 Feb 2013||Submitted||Manuscript version 2|
|24 Jun 2013||Reviewed||Reviewer Report - Douglas Jeffery|
|1 Jul 2013||Reviewed||Reviewer Report - Dana Horakova|
|6 Jul 2013||Reviewed||Reviewer Report - Ondrej Dolezal|
|11 Jul 2013||Author responded||Author comments - Chiara Zecca|
|Resubmission - Version 3|
|11 Jul 2013||Submitted||Manuscript version 3|
|27 Jul 2013||Reviewed||Reviewer Report - Ondrej Dolezal|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|30 Jul 2013||Editorially accepted|
|2 Aug 2013||Article published||10.1186/1471-2377-13-101|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.